Ginkgo Bioworks Holdings Stock Short Ratio

DNA Stock  USD 7.18  0.59  8.95%   
Ginkgo Bioworks Holdings fundamentals help investors to digest information that contributes to Ginkgo Bioworks' financial success or failures. It also enables traders to predict the movement of Ginkgo Stock. The fundamental analysis module provides a way to measure Ginkgo Bioworks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ginkgo Bioworks stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ginkgo Bioworks Holdings Company Short Ratio Analysis

Ginkgo Bioworks' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

 = 

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current Ginkgo Bioworks Short Ratio

    
  8.73 X  
Most of Ginkgo Bioworks' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Ginkgo Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Ginkgo Bioworks is extremely important. It helps to project a fair market value of Ginkgo Stock properly, considering its historical fundamentals such as Short Ratio. Since Ginkgo Bioworks' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ginkgo Bioworks' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ginkgo Bioworks' interrelated accounts and indicators.
1.00.93-0.8-0.860.650.820.92-0.640.870.980.960.930.880.90.770.850.99-0.20.890.950.40.39
1.00.91-0.83-0.830.630.850.89-0.60.850.970.970.920.850.880.740.821.0-0.180.870.970.370.36
0.930.91-0.74-0.910.640.720.94-0.680.90.940.880.980.880.940.820.90.91-0.430.940.870.640.65
-0.8-0.83-0.740.53-0.4-0.97-0.550.12-0.57-0.68-0.94-0.84-0.44-0.64-0.35-0.45-0.820.11-0.58-0.92-0.16-0.16
-0.86-0.83-0.910.53-0.68-0.49-0.930.89-0.99-0.91-0.76-0.86-0.91-0.93-0.98-0.98-0.860.62-0.99-0.78-0.8-0.78
0.650.630.64-0.4-0.680.530.65-0.550.610.670.570.580.620.850.660.650.66-0.320.670.620.440.43
0.820.850.72-0.97-0.490.530.57-0.10.510.70.930.810.470.670.320.440.830.040.550.910.050.05
0.920.890.94-0.55-0.930.650.57-0.850.920.980.790.870.990.920.90.970.89-0.340.960.780.60.61
-0.64-0.6-0.680.120.89-0.55-0.1-0.85-0.87-0.76-0.44-0.57-0.88-0.75-0.96-0.93-0.630.55-0.87-0.46-0.75-0.73
0.870.850.9-0.57-0.990.610.510.92-0.870.90.790.870.890.90.960.960.88-0.620.990.80.780.75
0.980.970.94-0.68-0.910.670.70.98-0.760.90.890.90.950.930.850.930.96-0.250.940.880.490.48
0.960.970.88-0.94-0.760.570.930.79-0.440.790.890.930.710.820.620.710.97-0.190.80.990.320.31
0.930.920.98-0.84-0.860.580.810.87-0.570.870.90.930.80.90.740.830.92-0.410.90.920.580.59
0.880.850.88-0.44-0.910.620.470.99-0.880.890.950.710.80.880.90.970.84-0.290.930.70.570.58
0.90.880.94-0.64-0.930.850.670.92-0.750.90.930.820.90.880.880.920.9-0.470.950.840.660.66
0.770.740.82-0.35-0.980.660.320.9-0.960.960.850.620.740.90.880.970.77-0.640.960.650.810.79
0.850.820.9-0.45-0.980.650.440.97-0.930.960.930.710.830.970.920.970.84-0.520.980.710.750.74
0.991.00.91-0.82-0.860.660.830.89-0.630.880.960.970.920.840.90.770.84-0.240.890.970.410.39
-0.2-0.18-0.430.110.62-0.320.04-0.340.55-0.62-0.25-0.19-0.41-0.29-0.47-0.64-0.52-0.24-0.57-0.24-0.94-0.92
0.890.870.94-0.58-0.990.670.550.96-0.870.990.940.80.90.930.950.960.980.89-0.570.810.760.75
0.950.970.87-0.92-0.780.620.910.78-0.460.80.880.990.920.70.840.650.710.97-0.240.810.350.33
0.40.370.64-0.16-0.80.440.050.6-0.750.780.490.320.580.570.660.810.750.41-0.940.760.351.0
0.390.360.65-0.16-0.780.430.050.61-0.730.750.480.310.590.580.660.790.740.39-0.920.750.331.0
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition

Ginkgo Price To Sales Ratio

Price To Sales Ratio

12.41

At present, Ginkgo Bioworks' Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting.
Based on the latest financial disclosure, Ginkgo Bioworks Holdings has a Short Ratio of 8.73 times. This is 123.85% higher than that of the Biotechnology sector and 17.81% higher than that of the Health Care industry. The short ratio for all United States stocks is 118.25% lower than that of the firm.

Ginkgo Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ginkgo Bioworks' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics of similar companies.
Ginkgo Bioworks is currently under evaluation in short ratio category among its peers.

Ginkgo Bioworks ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ginkgo Bioworks' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ginkgo Bioworks' managers, analysts, and investors.
Environmental
Governance
Social

Ginkgo Bioworks Institutional Holders

Institutional Holdings refers to the ownership stake in Ginkgo Bioworks that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ginkgo Bioworks' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ginkgo Bioworks' value.
Shares
Viking Global Investors Lp2024-09-30
3.6 M
Baillie Gifford & Co Limited.2024-09-30
3.4 M
T. Rowe Price Associates, Inc.2024-06-30
M
Salem Investment Counselors Inc2024-06-30
2.8 M
Bank Of America Corp2024-06-30
2.7 M
Vanguard Group Inc2024-09-30
2.6 M
Millennium Management Llc2024-06-30
2.2 M
Susquehanna International Group, Llp2024-06-30
M
Anchorage Advisors, Llc2024-09-30
1.7 M
Blackrock Inc2024-06-30
42 M
Two Sigma Advisers, Llc2024-06-30
31.4 M

Ginkgo Fundamentals

About Ginkgo Bioworks Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ginkgo Bioworks Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
Check out Ginkgo Bioworks Piotroski F Score and Ginkgo Bioworks Altman Z Score analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.89)
Revenue Per Share
4.291
Quarterly Revenue Growth
0.606
Return On Assets
(0.21)
Return On Equity
(0.64)
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.